We are live on ! Find out more
CCA

Canyon Capital Advisors Portfolio holdings

AUM $882M
1-Year Est. Return 62.77%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+62.77%
3 Year Est. Return
+78.01%
5 Year Est. Return
+85.45%
10 Year Est. Return
+347.5%
AUM
$2.84B
AUM Growth
+$151M
Cap. Flow
-$454M
Cap. Flow %
-15.95%
Top 10 Hldgs %
48.91%
Holding
126
New
7
Increased
7
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
SJR
Shaw Communications Inc.
SJR
+$90.5M
2
EHC icon
Encompass Health
EHC
+$50.1M
3
BYD icon
Boyd Gaming
BYD
+$49.8M
4
AMBP icon
Ardagh Metal Packaging
AMBP
+$43.7M
5
THC icon
Tenet Healthcare
THC
+$31.9M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$82.7M
2
DELL icon
Dell
DELL
+$60.5M
3
BERY
Berry Global Group, Inc.
BERY
+$44.6M
4
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
+$41.9M
5
ACIC
Atlas Crest Investment Corp.
ACIC
+$24.9M

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.02%
2 Technology 23.13%
3 Financials 10.37%
4 Consumer Discretionary 9.36%
5 Healthcare 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPALW
101
DELISTED
OPAL Fuels Inc. Warrant
OPALW
– –
0
– –
LGACW
102
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
– –
0
– –
KAHC.WS
103
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
– –
0
– –
GSQD.WS
104
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
– –
0
– –
AMPI.WS
105
DELISTED
Advanced Merger Partners Inc Warrants
AMPI.WS
– –
0
– –
AUR icon
106
Aurora
AUR
$11.7B
– –
-65,364
Closed -$646K
EGGF.U
107
DELISTED
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
– –
-1,300,000
Closed -$13M
AUS
108
DELISTED
Austerlitz Acquisition Corporation I
AUS
– –
-68,449
Closed -$679K
ACIC
109
DELISTED
Atlas Crest Investment Corp.
ACIC
– –
-2,500,000
Closed -$24.9M
CENH
110
DELISTED
Centricus Acquisition Corp. Class A Ordinary Share
CENH
– –
-500,000
Closed -$4.95M
ALXN
111
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-450,000
Closed -$82.7M
1 2 3 4
5

Similar funds

TAM
TCP Asset Management Columbus, Ohio $882M AUM 21.79% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
FFG
Fiduciary Financial Group San Rafael, California $882M AUM 23.98% 1-Year Est. Return
1IA
1834 Investment Advisors Milwaukee, Wisconsin $883M AUM 23.82% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $883M AUM 2.08% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $881M AUM 86.5% 1-Year Est. Return
AIA
Arbor Investment Advisors Winston Salem, North Carolina $883M AUM 17.9% 1-Year Est. Return

Canyon Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Canyon Capital Advisors held 126 positions worth $2.84B, up 5.6% from $2.69B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Canyon Capital Advisors withdrew a net $454M in Q3 2021, closing 6 positions and reducing 9 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $82.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Canyon Capital Advisors opened a new position in Shaw Communications Inc. worth $90.8M.

  • Canyon Capital Advisors's largest Q3 2021 buy was Shaw Communications Inc.: 3,125,000 shares worth $90.8M.
  • Canyon Capital Advisors added most to Tenet Healthcare in Q3 2021, an estimated $31.9M increase.
  • Canyon Capital Advisors's biggest Q3 2021 reduction was Dell, cutting an estimated $60.5M.
  • Canyon Capital Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $82.7M.
  • Canyon Capital Advisors's ten largest holdings make up 49% of its $2.84B portfolio in Q3 2021.
  • Canyon Capital Advisors opened 7 new positions and closed 6 in Q3 2021.
  • Canyon Capital Advisors's portfolio value rose 5.6% quarter-over-quarter to $2.84B.

Based on Canyon Capital Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.